Literature DB >> 29566824

Rivaroxaban With and Without Amiodarone in Renal Impairment.

Eleanor Jing Yi Cheong, Janice Jia Ni Goh, Yanjun Hong, Pipin Kojodjojo, Eric Chun Yong Chan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29566824     DOI： 10.1016/j.jacc.2018.01.044

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  7 in total

Review 1.  Drug-drug interactions in an era of multiple anticoagulants: a focus on clinically relevant drug interactions.

Authors:  Sara R Vazquez
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  The real world use of combined P-glycoprotein and moderate CYP3A4 inhibitors with rivaroxaban or apixaban increases bleeding.

Authors:  Sarah Hanigan; Jessica Das; Kristen Pogue; Geoffrey D Barnes; Michael P Dorsch
Journal:  J Thromb Thrombolysis       Date:  2020-05       Impact factor: 2.300

3.  The Magnitude of the Warfarin-Amiodarone Drug-Drug Interaction Varies With Renal Function: A Propensity-Matched Cohort Study.

Authors:  Todd A Miano; Wei Yang; Michael G S Shashaty; Athena Zuppa; Jeremiah R Brown; Sean Hennessy
Journal:  Clin Pharmacol Ther       Date:  2020-03-26       Impact factor: 6.875

4.  Amiodarone, Verapamil, or Diltiazem Use With Direct Oral Anticoagulants and the Risk of Hemorrhage in Older Adults.

Authors:  Kevin Hill; Ewa Sucha; Emily Rhodes; Sarah Bota; Gregory L Hundemer; Edward G Clark; Mark Canney; Ziv Harel; Tzu-Fei Wang; Marc Carrier; Harindra C Wijeysundera; Greg Knoll; Manish M Sood
Journal:  CJC Open       Date:  2021-11-13

5.  Physiologically-Based Pharmacokinetic Modelling to Investigate Baricitinib and Tofacitinib Dosing Recommendations for COVID-19 in Geriatrics.

Authors:  Ziteng Wang; Eric Chun Yong Chan
Journal:  Clin Pharmacol Ther       Date:  2022-04-27       Impact factor: 6.903

6.  Effect of ABCB1 genetic polymorphisms on the transport of rivaroxaban in HEK293 recombinant cell lines.

Authors:  Anne-Laure Sennesael; Nadtha Panin; Christelle Vancraeynest; Lionel Pochet; Anne Spinewine; Vincent Haufroid; Laure Elens
Journal:  Sci Rep       Date:  2018-07-12       Impact factor: 4.379

Review 7.  Drug-Drug Interactions Leading to Adverse Drug Reactions with Rivaroxaban: A Systematic Review of the Literature and Analysis of VigiBase.

Authors:  Silvia Fernandez; Camille Lenoir; Caroline Flora Samer; Victoria Rollason
Journal:  J Pers Med       Date:  2021-03-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.